Xintela AB (publ)

kr 0.14As of Sun 8 Nov 2026, 12:00 UTC
STO:XINTHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (24.39%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.94
PE TTM —
TSR TTM (67.20%)
Mkt cap kr 118.0M
ROIC (937.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.135
(1.29%)
(80.26%)
Hold 1|7|3|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
4.63%
0.07%
8.19%
15.02%
Revenuekr M
7.885
8.293
8.047
8.397
8.58%
17.32%
12.53%
11.62%
Peers (US$11.93M)
Cap (US$)
PE
10.99M
—
Capital
TTM
5Y
10Y
Leveragex
1.018
(0.019)
(0.014)
EBIT/Intx
0.984
0.109
0.108
Own earn%
(67.59)
(59.76)
(55.83)
Sh yield%
28.25
27.09
26.58
Owners
Insiders/Inst%
14.85
89.12
Short interest%
1.38
SBC / revenue%
0.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
10–21
$1 testx
—
Incr. ROIC%
0